Friends of MannKInd

[Phaeton]

I would encourage any of you who are SHORT OR LONG to go to this web site and watch the 23 minute long video by Dr. Edelman which is directed toward the medical professional - Doctors, Nurses and others who are in the Diabetes field. Then go and review the 24 slides that again are geared toward the professional on how and why Afrezza works. After reviewing this material than you can make up your own mind. The question you need to ask and answer after watching reviewing this material is Sanofi committed to Afrezza. Only you can make that determination for yourself.

http://www.medscape.org/viewarticle/840611
You will have to sign in to watch the video and see the slides.

Here is a basic review:
This activity is intended for primary care physicians, diabetologists, endocrinologists, pulmonologists, nurses, and pharmacists who manage patients with diabetes.

The goal of this activity is to review the need for advances in rapid-acting insulin therapy and appreciate the unique mechanism of action and pharmacokinetics/pharmacodynamics of inhaled insulin compared with other currently available insulin products.

Upon completion of this activity, participants will be able to:

Review the limitations of available rapid-acting insulin products
Examine the mechanism of action of the inhaled insulin products recently approved
Compare the pharmacokinetics and pharmacodynamics of inhaled insulin with those of other currently available prandial insulin products
Differentiate new inhaled insulins from past products